EP1276755A4 - Nouveaux composes - Google Patents

Nouveaux composes

Info

Publication number: EP1276755A4
Authority: EP; European Patent Office
Prior art keywords: novel compounds; novel; compounds
Prior art date: 2000-04-27
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP01930760A

Other languages

German (de)

English (en)

Other versions

EP1276755A1 (fr

Inventor

Pankaj Agarwal

Paul R Murdock

Safia K Rizvi

Randall F Smith

Zhaoying Xiang

Karen S Kabnick

Ying-Ta Lai

Qing Xie

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

SmithKline Beecham Ltd

SmithKline Beecham Corp

Original Assignee

SmithKline Beecham Ltd

SmithKline Beecham Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-04-27

Filing date

2001-04-26

Publication date

2004-03-31

2001-04-26 Application filed by SmithKline Beecham Ltd, SmithKline Beecham Corp filed Critical SmithKline Beecham Ltd

2003-01-22 Publication of EP1276755A1 publication Critical patent/EP1276755A1/fr

2004-03-31 Publication of EP1276755A4 publication Critical patent/EP1276755A4/fr

Status Withdrawn legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biochemistry (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Zoology (AREA)
Biomedical Technology (AREA)
Reproductive Health (AREA)
Wood Science & Technology (AREA)
Biotechnology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Pulmonology (AREA)
Rheumatology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Immunology (AREA)
Microbiology (AREA)
Hematology (AREA)
Diabetes (AREA)
Oncology (AREA)
General Engineering & Computer Science (AREA)
Dermatology (AREA)
Physical Education & Sports Medicine (AREA)
Psychology (AREA)
Toxicology (AREA)

EP01930760A 2000-04-27 2001-04-26 Nouveaux composes Withdrawn EP1276755A4 (fr)

Applications Claiming Priority (9)

Application Number	Priority Date	Filing Date	Title
US19996300P	2000-04-27	2000-04-27
US199963P		2000-04-27
US20333600P	2000-05-11	2000-05-11
US203336P		2000-05-11
US20708700P	2000-05-25	2000-05-25
US207087P		2000-05-25
US20754600P	2000-05-26	2000-05-26
US207546P		2000-05-26
PCT/US2001/013360 WO2001081363A1 (fr)	2000-04-27	2001-04-26	Nouveaux composes

Publications (2)

Publication Number	Publication Date
EP1276755A1 EP1276755A1 (fr)	2003-01-22
EP1276755A4 true EP1276755A4 (fr)	2004-03-31

Family

ID=27498358

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP01930760A Withdrawn EP1276755A4 (fr)	2000-04-27	2001-04-26	Nouveaux composes

Country Status (15)

Country	Link
EP (1)	EP1276755A4 (fr)
JP (1)	JP2003530869A (fr)
KR (1)	KR20030032940A (fr)
CN (1)	CN1439017A (fr)
AU (1)	AU2001257265A1 (fr)
BR (1)	BR0110402A (fr)
CA (1)	CA2407449A1 (fr)
CZ (1)	CZ20023548A3 (fr)
HK (1)	HK1053840A1 (fr)
HU (1)	HUP0300595A3 (fr)
IL (1)	IL152416A0 (fr)
MX (1)	MXPA02010692A (fr)
NO (1)	NO20025151L (fr)
PL (1)	PL358580A1 (fr)
WO (1)	WO2001081363A1 (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7034132B2 (en)	2001-06-04	2006-04-25	Anderson David W	Therapeutic polypeptides, nucleic acids encoding same, and methods of use
US6558936B1 (en) *	1999-10-01	2003-05-06	Millennium Pharmaceuticals, Inc.	Human lipase proteins, nucleic acids encoding them, and uses of both of these
US6630335B1 (en)	2000-02-11	2003-10-07	Millennium Pharmaceuticals, Inc.	14171 protein kinase, a novel human protein kinase and uses thereof
NZ523122A (en) *	2000-06-22	2004-06-25	Smithkline Beecham Corp	Polypeptides and polynucleotides and methods of identifying agonists and antagonists in relation to treatment of diseases
AU2001271623A1 (en) *	2000-06-30	2002-01-14	Incyte Genomics, Inc.	Human extracellular matrix (ecm)-related tumor marker
US6924364B2 (en)	2000-08-04	2005-08-02	Zymogenetics, Inc.	Human secreted protein, Zzp1
EP1311675B1 (fr) *	2000-08-22	2007-02-07	Agensys, Inc.	Acide nucleique et proteine correspondante nomme 158p1d7 servant dans le traitement et la detection du cancer de la vesicule et d'autres cancers
US7358353B2 (en)	2000-08-22	2008-04-15	Agensys, Inc.	Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers
US6875570B2 (en)	2000-09-27	2005-04-05	Curagen Corporation	Proteins and nucleic acids encoding same
WO2002026826A2 (fr) *	2000-09-27	2002-04-04	Curagen Corporation	Nouvelles proteines et acides nucleiques codant pour celles-ci
CA2430257A1 (fr) *	2000-11-28	2002-06-06	Amgen, Inc.	Molecules associees au facteur de croissance transformant-beta et leurs applications
CA2439637A1 (fr)	2001-03-08	2002-09-19	Immunex Corporation	Polypeptides du type serpine humaine
US6921807B2 (en)	2001-03-29	2005-07-26	Zymogenetics, Inc.	Proteinase inhibitor ZSERP9
US7033790B2 (en)	2001-04-03	2006-04-25	Curagen Corporation	Proteins and nucleic acids encoding same
US20020172995A1 (en) *	2001-05-17	2002-11-21	Wei Shao	Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
US20040259779A1 (en) *	2001-07-06	2004-12-23	Teit Johansen	Novel neurotrophic factors
US20030215852A1 (en) *	2002-04-01	2003-11-20	Wyeth	Novel pancortin-Pablo protein interactions and methods of use thereof
AU2004210975B2 (en) *	2003-02-10	2008-04-10	Agensys, Inc.	Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers
US7422906B2 (en)	2003-02-10	2008-09-09	Taisho Pharmaceutical Co., Ltd.	Apoptosis-inducing gene and utilization of the same
CA2534353A1 (fr) *	2003-08-01	2005-02-10	Zymogenetics, Inc.	Proteine zacrp11 liee au complement d'adipocyte
US7399469B2 (en)	2004-03-26	2008-07-15	Pdl Biopharma, Inc.	Anti-LFL2 antibodies for the diagnosis, prognosis and treatment of cancer
PL2887959T3 (pl)	2012-08-23	2019-04-30	Agensys Inc	Koniugaty leków i przeciwciał (adc), które wiążą białka 158p1d7
US10828318B2 (en) *	2016-01-06	2020-11-10	Yeda Research And Development Co. Ltd.	Compositions and methods for treating malignant, autoimmune and inflammatory diseases
CN108178797B (zh) *	2017-12-29	2020-12-01	西南大学	一种抗家蚕BmSRC多克隆抗血清、制备方法及应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU6782894A (en) *	1994-05-05	1995-11-29	Human Genome Sciences, Inc.	Human dnase
US5830744A (en) *	1995-06-06	1998-11-03	Human Genome Sciences, Inc.	Gene encoding human Dnase
AU3395900A (en) *	1999-03-12	2000-10-04	Human Genome Sciences, Inc.	Human lung cancer associated gene sequences and polypeptides

2001
- 2001-04-26 EP EP01930760A patent/EP1276755A4/fr not_active Withdrawn
- 2001-04-26 PL PL01358580A patent/PL358580A1/xx unknown
- 2001-04-26 IL IL15241601A patent/IL152416A0/xx unknown
- 2001-04-26 WO PCT/US2001/013360 patent/WO2001081363A1/fr not_active Ceased
- 2001-04-26 CA CA002407449A patent/CA2407449A1/fr not_active Abandoned
- 2001-04-26 HK HK03104434.3A patent/HK1053840A1/zh unknown
- 2001-04-26 BR BR0110402-0A patent/BR0110402A/pt not_active IP Right Cessation
- 2001-04-26 AU AU2001257265A patent/AU2001257265A1/en not_active Abandoned
- 2001-04-26 HU HU0300595A patent/HUP0300595A3/hu unknown
- 2001-04-26 JP JP2001578451A patent/JP2003530869A/ja not_active Withdrawn
- 2001-04-26 MX MXPA02010692A patent/MXPA02010692A/es unknown
- 2001-04-26 CN CN01811752A patent/CN1439017A/zh active Pending
- 2001-04-26 KR KR1020027014463A patent/KR20030032940A/ko not_active Withdrawn
- 2001-04-26 CZ CZ20023548A patent/CZ20023548A3/cs unknown
2002
- 2002-10-25 NO NO20025151A patent/NO20025151L/no not_active Application Discontinuation

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
No further relevant documents disclosed *

Also Published As

Publication number	Publication date
HUP0300595A2 (hu)	2003-06-28
IL152416A0 (en)	2003-05-29
HK1053840A1 (zh)	2003-11-07
PL358580A1 (en)	2004-08-09
EP1276755A1 (fr)	2003-01-22
MXPA02010692A (es)	2003-03-10
CZ20023548A3 (cs)	2003-05-14
KR20030032940A (ko)	2003-04-26
NO20025151L (no)	2002-12-13
NO20025151D0 (no)	2002-10-25
BR0110402A (pt)	2003-02-11
HUP0300595A3 (en)	2007-06-28
CA2407449A1 (fr)	2001-11-01
JP2003530869A (ja)	2003-10-21
CN1439017A (zh)	2003-08-27
AU2001257265A1 (en)	2001-11-07
WO2001081363A1 (fr)	2001-11-01

Publication	Publication Date	Title
AU7476301A (en)	2002-01-02	Novel compounds
HUP0300595A3 (en)	2007-06-28	Novel compounds
AU9261901A (en)	2002-03-26	Novel compounds
GB0003019D0 (en)	2000-03-29	Novel compounds
EP1255771A4 (fr)	2004-09-29	Nouveaux composes
GB0008464D0 (en)	2000-05-24	Novel compounds
EP1292617A4 (fr)	2005-04-06	Composes
EP1472352A4 (fr)	2005-10-12	Nouveaux composes
EP1343813A4 (fr)	2004-11-17	Nouveaux composes
AU7476401A (en)	2002-01-02	Novel compounds
EP1276866A4 (fr)	2005-03-16	Nouveaux composes
GB0004149D0 (en)	2000-04-12	Novel compounds
EP1299530A4 (fr)	2005-03-09	Nouveaux composes
GB0003636D0 (en)	2000-04-05	Novel compounds
GB0001898D0 (en)	2000-03-22	Novel compounds
GB0002402D0 (en)	2000-03-22	Novel compounds
GB0004196D0 (en)	2000-04-12	Novel compounds
EG22332A (en)	2002-12-31	Novel compounds
GB0003103D0 (en)	2000-03-29	Novel compounds
GB0006545D0 (en)	2000-05-10	Novel compounds
GB0002195D0 (en)	2000-03-22	Novel compounds
GB0003112D0 (en)	2000-03-29	Novel compounds
GB0008421D0 (en)	2000-05-24	Novel compounds
GB0001550D0 (en)	2000-03-15	Novel compounds
GB0002401D0 (en)	2000-03-22	Novel compounds

Legal Events

Date	Code	Title	Description
2002-12-06	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2003-01-22	17P	Request for examination filed	Effective date: 20021024
2003-01-22	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
2003-01-22	AX	Request for extension of the european patent	Free format text: AL;LT;LV;MK;RO;SI PAYMENT 20021024
2004-03-31	A4	Supplementary search report drawn up and despatched	Effective date: 20040212
2004-09-29	17Q	First examination report despatched	Effective date: 20040811
2006-05-12	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2006-06-14	18D	Application deemed to be withdrawn	Effective date: 20051222
2009-12-04	REG	Reference to a national code	Ref country code: HK Ref legal event code: WD Ref document number: 1053840 Country of ref document: HK